These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36466981)

  • 1. Secondary Acute Myeloid Leukemia in a Chronic Myeloid Leukemia Patient in Deep Molecular Response-An Unusual Case Report.
    Bharathi Devi G; Jayachandran PK; Arumugam JR; Bommannan K; Sundersingh S
    South Asian J Cancer; 2022 Apr; 11(2):175-177. PubMed ID: 36466981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
    Zhu H; Yang B; Liu J; Wu W; Ling Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18888. PubMed ID: 32011516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches.
    Asnafi AA; Deris Zayeri Z; Shahrabi S; Zibara K; Vosughi T
    J Cell Physiol; 2019 May; 234(5):5798-5806. PubMed ID: 30430567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia.
    Jaitly V; Wang W; Hu S
    Stem Cell Investig; 2015; 2():13. PubMed ID: 27358881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
    Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of clonal chromosomal abnormalities in Philadelphia negative cells in CML patients after treated with tyrosine kinase inhibitors.
    Ni H; Sun X; Xu Y; Lyle D; Petersen P; Zhao X; Drum H; You B; Liu D; Liu C; Jiang JG
    Cancer Genet; 2019 Oct; 238():44-49. PubMed ID: 31425925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
    Nakamura F; Arai H; Nannya Y; Ichikawa M; Furuichi S; Nagasawa F; Takahashi W; Handa T; Nakamura Y; Tanaka H; Nakamura Y; Sasaki K; Miyano S; Ogawa S; Mitani K
    Int J Hematol; 2021 Jun; 113(6):936-940. PubMed ID: 33400143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.
    Wasilewska EM; Panasiuk B; Gniot M; Sawicka A; Kozłowska K; Lewandowski K; Kłoczko J; Midro AT
    Cancer Genet; 2017 Oct; 216-217():1-9. PubMed ID: 29025581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrupt evolution of Philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome.
    Fukunaga A; Sakoda H; Iwamoto Y; Inano S; Sueki Y; Yanagida S; Arima N
    Eur J Haematol; 2013 Mar; 90(3):245-9. PubMed ID: 23240925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of recurrent chromosomal abnormalities and the Philadelphia chromosome in acute and chronic myeloid leukemias: report of five cases and review of literature.
    Gong JY; Zhang ZH; Zhang W; Wang HJ; Feng XF; Zhou J; Zhu GQ
    Mol Cytogenet; 2020; 13():34. PubMed ID: 32831907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.
    Wang L; Zhu K; Zha X; Chen S; Yang L; Chen S; Li Y
    J Hematol Oncol; 2010 Apr; 3():14. PubMed ID: 20377918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tyrosine kinase inhibitors for controlling Ph+ clone and additional clonal abnormalities in a chronic myeloid leukemia.
    Ganguly BB; Mandal S; Banerjee D; Kadam NN
    J Cancer Res Ther; 2022; 18(3):760-764. PubMed ID: 35900551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.
    Groves MJ; Sales M; Baker L; Griffiths M; Pratt N; Tauro S
    Cancer Genet; 2011 Jan; 204(1):39-44. PubMed ID: 21356190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation.
    Imataki O; Ishida T; Kubo H; Uemura M; Nanya Y; Kawakami K; Ogawa S; Kadowaki N
    Case Rep Oncol; 2020; 13(1):449-455. PubMed ID: 32399015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
    Carratt SA; Brewer D; Maxson JE; Druker BJ; Braun TP
    Biomark Res; 2021 Jan; 9(1):8. PubMed ID: 33516272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia.
    Krishna Chandran R; Geetha N; Sakthivel KM; Suresh Kumar R; Jagathnath Krishna KMN; Sreedharan H
    Front Oncol; 2019; 9():88. PubMed ID: 30891424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
    Schmidt M; Rinke J; Schäfer V; Schnittger S; Kohlmann A; Obstfelder E; Kunert C; Ziermann J; Winkelmann N; Eigendorff E; Haferlach T; Haferlach C; Hochhaus A; Ernst T
    Leukemia; 2014 Dec; 28(12):2292-9. PubMed ID: 25212276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic polyclonality in hematologic malignancies.
    Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
    Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.